MONOCLONAL ANTIBODY AGAINST EL, INHIBITING EL ENZYMATIC ACTIVITY

摘要

Provided are: a monoclonal antibody or an antibody fragment thereof that selectively inhibits EL activity and is effective in the treatment of arteriosclerosis or metabolic syndrome; and a drug composition containing same as the active ingredient.